BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 28170002)

  • 1. Regulation of dopaminergic function: an [
    Jauhar S; Veronese M; Rogdaki M; Bloomfield M; Natesan S; Turkheimer F; Kapur S; Howes OD
    Transl Psychiatry; 2017 Feb; 7(2):e1027. PubMed ID: 28170002
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparative assessment of 6-[
    Becker G; Bahri MA; Michel A; Hustadt F; Garraux G; Luxen A; Lemaire C; Plenevaux A
    J Neurochem; 2017 May; 141(4):626-635. PubMed ID: 28294334
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of apomorphine infusion on dopamine synthesis rate relates to dopaminergic tone.
    Torstenson R; Hartvig P; Långström B; Bastami S; Antoni G; Tedroff J
    Neuropharmacology; 1998 Aug; 37(8):989-95. PubMed ID: 9833628
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The test-retest reliability of 18F-DOPA PET in assessing striatal and extrastriatal presynaptic dopaminergic function.
    Egerton A; Demjaha A; McGuire P; Mehta MA; Howes OD
    Neuroimage; 2010 Apr; 50(2):524-531. PubMed ID: 20034580
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of a genetic variant at the schizophrenia associated AS3MT/BORCS7 locus on striatal dopamine function: A PET imaging study.
    D'Ambrosio E; Dahoun T; Pardiñas AF; Veronese M; Bloomfield MAP; Jauhar S; Bonoldi I; Rogdaki M; Froudist-Walsh S; Walters JTR; Howes OD
    Psychiatry Res Neuroimaging; 2019 Sep; 291():34-41. PubMed ID: 31386983
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of the antipsychotic risperidone on dopamine synthesis in human brain measured by positron emission tomography with L-[beta-11C]DOPA: a stabilizing effect for dopaminergic neurotransmission?
    Ito H; Takano H; Takahashi H; Arakawa R; Miyoshi M; Kodaka F; Okumura M; Otsuka T; Suhara T
    J Neurosci; 2009 Oct; 29(43):13730-4. PubMed ID: 19864585
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serotonin and dopamine transporter PET changes in the premotor phase of LRRK2 parkinsonism: cross-sectional studies.
    Wile DJ; Agarwal PA; Schulzer M; Mak E; Dinelle K; Shahinfard E; Vafai N; Hasegawa K; Zhang J; McKenzie J; Neilson N; Strongosky A; Uitti RJ; Guttman M; Zabetian CP; Ding YS; Adam M; Aasly J; Wszolek ZK; Farrer M; Sossi V; Stoessl AJ
    Lancet Neurol; 2017 May; 16(5):351-359. PubMed ID: 28336296
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The relationship between grey matter volume and striatal dopamine function in psychosis: a multimodal
    D'Ambrosio E; Jauhar S; Kim S; Veronese M; Rogdaki M; Pepper F; Bonoldi I; Kotoula V; Kempton MJ; Turkheimer F; Kwon JS; Kim E; Howes OD
    Mol Psychiatry; 2021 Apr; 26(4):1332-1345. PubMed ID: 31690805
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Determinants of treatment response in first-episode psychosis: an
    Jauhar S; Veronese M; Nour MM; Rogdaki M; Hathway P; Turkheimer FE; Stone J; Egerton A; McGuire P; Kapur S; Howes OD
    Mol Psychiatry; 2019 Oct; 24(10):1502-1512. PubMed ID: 29679071
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of long-term estrogen therapy on dopaminergic responsivity in post-menopausal women--a preliminary study.
    Craig MC; Cutter WJ; Wickham H; van Amelsvoort TA; Rymer J; Whitehead M; Murphy DG
    Psychoneuroendocrinology; 2004 Nov; 29(10):1309-16. PubMed ID: 15288710
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dopamine function in cigarette smokers: an [¹⁸F]-DOPA PET study.
    Bloomfield MA; Pepper F; Egerton A; Demjaha A; Tomasi G; Mouchlianitis E; Maximen L; Veronese M; Turkheimer F; Selvaraj S; Howes OD
    Neuropsychopharmacology; 2014 Sep; 39(10):2397-404. PubMed ID: 24718373
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differential responses in central dopaminergic activity induced by apomorphine in IPL nude rat.
    Estrella CR; Bregonzio C; Cabrera RJ
    Behav Brain Res; 2002 Jul; 133(2):143-8. PubMed ID: 12110447
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dopamine synthesis capacity in patients with treatment-resistant schizophrenia.
    Demjaha A; Murray RM; McGuire PK; Kapur S; Howes OD
    Am J Psychiatry; 2012 Nov; 169(11):1203-10. PubMed ID: 23034655
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of AUT00206, a Kv3 potassium channel modulator, on dopamine synthesis capacity and the reliability of [
    Angelescu I; Kaar SJ; Marques TR; Borgan F; Veronesse M; Sharman A; Sajjala A; Deakin B; Hutchison J; Large C; Howes OD
    J Psychopharmacol; 2022 Sep; 36(9):1061-1069. PubMed ID: 36164687
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dopaminergic modulation of striato-frontal connectivity during motor timing in Parkinson's disease.
    Jahanshahi M; Jones CR; Zijlmans J; Katzenschlager R; Lee L; Quinn N; Frith CD; Lees AJ
    Brain; 2010 Mar; 133(Pt 3):727-45. PubMed ID: 20305278
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Midbrain dopamine function in schizophrenia and depression: a post-mortem and positron emission tomographic imaging study.
    Howes OD; Williams M; Ibrahim K; Leung G; Egerton A; McGuire PK; Turkheimer F
    Brain; 2013 Nov; 136(Pt 11):3242-51. PubMed ID: 24097339
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reproducibility of PET measurement for presynaptic dopaminergic functions using L-[β-(11)C]DOPA and [(18)F]FE-PE2I in humans.
    Suzuki M; Ito H; Kodaka F; Takano H; Kimura Y; Fujiwara H; Sasaki T; Takahata K; Nogami T; Nagashima T; Nengaki N; Kawamura K; Zhang MR; Varrone A; Halldin C; Okubo Y; Suhara T
    Nucl Med Commun; 2014 Mar; 35(3):231-7. PubMed ID: 24468851
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The utility of (11)C-arachidonate PET to study in vivo dopaminergic neurotransmission in humans.
    Thambisetty M; Gallardo KA; Liow JS; Beason-Held LL; Umhau JC; Bhattacharjee AK; Der M; Herscovitch P; Rapoport JL; Rapoport SI
    J Cereb Blood Flow Metab; 2012 Apr; 32(4):676-84. PubMed ID: 22167235
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Direct comparison of FP-CIT SPECT and F-DOPA PET in patients with Parkinson's disease and healthy controls.
    Eshuis SA; Jager PL; Maguire RP; Jonkman S; Dierckx RA; Leenders KL
    Eur J Nucl Med Mol Imaging; 2009 Mar; 36(3):454-62. PubMed ID: 19037637
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The link between dopamine function and apathy in cannabis users: an [18F]-DOPA PET imaging study.
    Bloomfield MA; Morgan CJ; Kapur S; Curran HV; Howes OD
    Psychopharmacology (Berl); 2014 Jun; 231(11):2251-9. PubMed ID: 24696078
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.